SSPL Securities Private Limited

Friday 23 May, 2025 08:09 PM

Kirloskar Inds gains after Q4 PAT climbs 95% QoQ to Rs 47 cr Shilpa Medicare zooms as arm partners with Orion Corporation AIA Engineering gains after Q4 PAT rises 10% QoQ to Rs 285 crore Alembic Pharma receives USFDA nod for Amlodipine and Atorvastatin Tablets Bharti Airtel Ltd Partly Paidup leads losers in 'A' group Dhabriya Polywood soars as Q4 PAT jumps 32% YoY to Rs 5 crore Devyani Intl Q4 net loss widens to Rs 15 cr Premier Explosives Ltd leads losers in 'B' group Premier Explosives drops after weak Q4 numbers Greenpanel Inds Q4 PAT falls 1% YoY to Rs 29 crore Volumes spurt at Honasa Consumer Ltd counter BEML gains as Q4 PAT jumps 12% YoY to Rs 288 cr Healthcare shares slide Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr Mankind Pharma Ltd slips for fifth straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Indoco Remedies gains after receiving USFDA nod for Allopurinol drug

23-May-25 11:34 Hrs IST

Allopurinol is used to prevent or lower high uric acid levels in the blood. It is also used to prevent or lower excess uric acid levels caused by cancer medicines or in patients with kidney stones.

The drug is the generic equivalent of the reference listed drug (RLD), Zyloprim, marketed by Casper Pharma LLC.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs).

The pharmaceutical company reported a standalone net loss of Rs 10.23 crore in Q3 FY25 as against a net profit of Rs 20.01 crore posted in Q3 FY24. Revenue from operations stood at Rs 364.91 crore in the third quarter of FY25, down 18.61% as against Rs 448.38 crore posted in Q3 FY24.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 41052290

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)